PharmAthene Declares $2.91 Special Cash Dividend on Common Stock
The special dividend, totaling an aggregate payment of approximately
The U.S. federal income tax treatment of holding common stock to any particular stockholder will depend on the stockholder's particular tax circumstances.
Forward-Looking Statement Disclaimer
Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; "will"; "project"; or similar statements are forward-looking statements. Risks and uncertainties are detailed from time to time in
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pharmathene-declares-291-special-cash-dividend-on-common-stock-300365470.html
Melody Carey, Rx Communications Group, LLC, Phone: (917) 322-2571, email@example.com